Imunon, Inc.
IMNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000749647
In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Imunon, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 22 | 22 | 0 |
| Shares | 488.7K | 425.6K | −63.1K (−12.9%) |
| Value | $818.1K | $572.7K | −$245.4K (−30.0%) |
New holders (4)
Institutions that held Imunon, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 14,665 | $19.8K | 0.00% |
| Citigroup Inc | 301 | $406 | 0.00% |
| Bank of America Corp | 16 | $22 | 0.00% |
| The PNC Financial Services Group, Inc. | 12 | $16 | 0.00% |
Sold out (4)
Institutions that held Imunon, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Citadel Advisors LLC | 32,047 | $54.0K |
| Virtu Financial LLC | 10,934 | $18.0K |
| Investors Asset Management of Georgia Inc | 5,000 | $8.00K |
| Cutler Group LP | 100 | $0 |